防御 发表于 2025-3-25 03:36:22

http://reply.papertrans.cn/3/270/26945/26945-21.png

Progesterone 发表于 2025-3-25 08:47:34

http://reply.papertrans.cn/3/270/26945/26945-22.png

Ballerina 发表于 2025-3-25 13:01:11

Submitted on: 21 December 2006.
Revised on: 29 December 2006.
Accepted on: 17 January 2007.
Revista Espanola de Quimioterapia

不成比例 发表于 2025-3-25 17:42:41

Submitted on: 03 October 1999.
Revised on: 10 November 1999.
Accepted on: 29 November 1999.
Revista Espanola de Quimioterapia

epicondylitis 发表于 2025-3-25 21:44:14

Submitted on: 05 November 2001.
Revised on: 05 December 2001.
Accepted on: 23 December 2001.
Revista Espanola de Quimioterapia

议程 发表于 2025-3-26 00:29:58

http://reply.papertrans.cn/3/270/26945/26945-26.png

表示向前 发表于 2025-3-26 04:24:12

http://reply.papertrans.cn/3/270/26945/26945-27.png

ADAGE 发表于 2025-3-26 12:01:58

http://reply.papertrans.cn/3/270/26945/26945-28.png

Dorsal 发表于 2025-3-26 13:19:42

Submitted on: 12 July 2010.
Revised on: 31 July 2010.
Accepted on: 24 August 2010.
Revista Espanola de Quimioterapia

你敢命令 发表于 2025-3-26 20:14:35

http://reply.papertrans.cn/3/270/26945/26945-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊Revista Espanola de Quimioterapia 2024/2025影响因子:1.993 (REV ESP QUIM) (0214-3429). (PHARMACOLOGY & PHARMACY)(药理学与药